Retinal Vein Occlusion Subtypes Can Be Treated With High Dose Aflibercept - Ophthalmology Advisor Researchers compared the use of aflibercept 8 mg and 2 mg in patients with various retinal vein occlusion subtypes.

#AAO2025: Treatment with high dose #Aflibercept 8 mg can lead to similar #VisualOutcomes with fewer injections for patients with various #RetinalVeinOcclusion (RVO) subtypes.

Read more: https://bit.ly/4o3qTSp

#Ophthalmology #EyeSky #RVO #MedSky

This study reveals that primary active #OcularToxoplasmosis (OT) is the most common form of OT in China and adoption of timely diagnosis on the basis of #ocular characteristics and effective treatment would prevent poor #VisualOutcomes and recurrence. #medsky

Read: buff.ly/RbmJP5T